PTC258 is an optimized kinetin derivative and brain-penetrant splicing modulator studied for its therapeutic potential in addressing ELP1 splicing defects associated with neurodegenerative conditions like… Read more
PTC258 is an optimized kinetin derivative and brain-penetrant splicing modulator studied for its therapeutic potential in addressing ELP1 splicing defects associated with neurodegenerative conditions like familial dysautonomia. This category provides access to PTC258 and its related compounds, including synthetic impurities, metabolic derivatives, and stable isotope labelled standards, which are indispensable for comprehensive analytical testing. Pharmaceutical laboratories rely on these materials to perform accurate method development, method validation, and rigorous impurity profiling, ensuring the consistent quality of the drug substance. By offering essential reference standards that mirror the drug’s structural complexity, this collection supports the necessary monitoring of degradation products and active compounds throughout the pharmaceutical development lifecycle and quality control assessments.